Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
569-06-003 ISMRM Abstract

Spatial variations of macromolecular and transverse relaxation properties across the substantia nigra

Primary: Neuro - Psychiatric Disorders
Secondary: Contrast Mechanisms - Magnetization Transfer
569-06-003 · Magnetization Transfer and Relaxometry · Wednesday, 13 May, 4:55 PM–5:50 PM · Digital Posters Row J
Keywords: Quantitative Magnetization Transfer Iron quantification Substantia Nigra Neuromelanin-Sensitive MRI Transverse relaxation rates
Accepted
Yu Veronica Sui1, Zakia Ben Youss1,2, Gayatri M Schur1,2, Mariana Lazar1
1Bernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University Grossman School of Medicine, New York, New York, United States of America
2Vilcek Institute of Graduate Biomedical Sciences, New York University Grossman School of Medicine, New York, United States of America
Presenting Author: Faye F McKenna

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1. Trujillo P, Aumann MA and Claassen DO. Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function. Brain 2024; 147: 337-351. DOI: 10.1093/brain/awad300. [doi]
2. 2. Cassidy CM, Zucca FA, Girgis RR, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 5108-5117. 2019/02/24. DOI: 10.1073/pnas.1807983116. [doi]
3. 3. Wengler K, Trujillo P, Cassidy CM, et al. Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry. Neuropsychopharmacology 2024; 50: 137-152. 2024/08/20. DOI: 10.1038/s41386-024-01934-y. [doi]
4. 4. He N, Ghassaban K, Huang P, et al. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease. Neuroimage 2021; 230: 117810. 20210130. DOI: 10.1016/j.neuroimage.2021.117810. [doi]
5. 5. Lee H, Baek SY, Kim EJ, et al. MRI T(2) and T(2)* relaxometry to visualize neuromelanin in the dorsal substantia nigra pars compacta. Neuroimage 2020; 211: 116625. 20200211. DOI: 10.1016/j.neuroimage.2020.116625. [doi]
6. 6. Yarnykh VL. Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping. Magn Reson Med 2016; 75: 2100-2106. DOI: 10.1002/mrm.25811. [doi]
7. 7. Yarnykh VL. Fast macromolecular proton fraction mapping from a single off-resonance magnetization transfer measurement. Magn Reson Med 2012; 68: 166-178. DOI: 10.1002/mrm.23224. [doi]
8. 8. Samsonov AA, Mossahebi P, Anderson A, et al. High Resolution, Motion Corrected Mapping of Macromolecular Proton Fraction (MPF). Clinically Acceptable Time Using 3D Undersampled Radials. In Proc of ISMRM. 2014, p. 3337.
9. 9. Mossahebi P, Yarnykh VL and Samsonov A. Analysis and correction of biases in cross-relaxation MRI due to biexponential longitudinal relaxation. Magn Reson Med 2014; 71: 830-838. DOI: 10.1002/mrm.24677. [doi]
10. 10. Miller AJ and Joseph PM. The use of power images to perform quantitative analysis on low SNR MR images. Magnetic resonance imaging 1993; 11: 1051-1056. 1993/01/01. DOI: 10.1016/0730-725x(93)90225-3. [doi]
11. 11. Mori S, Wakana S, Van Zijl PC, et al. MRI atlas of human white matter. Elsevier, 2005. PMCID: PMC8133945.
12. 12. Baniasadi M, Petersen MV, Goncalves J, et al. DBSegment: Fast and robust segmentation of deep brain structures considering domain generalization. Hum Brain Mapp 2023; 44: 762-778. 20221017. DOI: 10.1002/hbm.26097. [doi]
13. 13. Priovoulos N, van Boxel SCJ, Jacobs HIL, et al. Unraveling the contributions to the neuromelanin-MRI contrast. Brain Struct Funct 2020; 225: 2757-2774. 20201022. DOI: 10.1007/s00429-020-02153-z. [doi]
14. 14. Trujillo P, Summers PE, Smith AK, et al. Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches. Neuroradiology 2017; 59: 1251-1263. 20171006. DOI: 10.1007/s00234-017-1911-2. [doi]
15. 15. Brammerloh M, Morawski M, Friedrich I, et al. Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry. Neuroimage 2021; 239: 118255. 20210611. DOI: 10.1016/j.neuroimage.2021.118255. [doi]
16. 16. Snyder AM and Connor JR. Iron, the substantia nigra and related neurological disorders. Biochimica et biophysica acta 2009; 1790: 606-614. 20080820. DOI: 10.1016/j.bbagen.2008.08.005. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/569-06-003